GlassScriptPhysician profile
Zachary Snow
NPI 1861051716
$2,155.41
in general payments reported to CMS, 2019-2025
20 companies · $914 in 2025
The $914 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $137 · 2023: $532 · 2024: $370 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,816.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,175.42 | 2021-2025 | Lithovue, Rezum Generator, Upsylon |
| Olympus America INC. | $179.00 | 2022-2025 | Itind System, Bovie |
| Procept Biorobotics Corporation | $150.44 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $118.56 | 2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $94.10 | 2024-2025 | Xiaflex, Aveed |
| Conmed Corporation | $55.56 | 2025 | Airseal |
| Medtronic, INC. | $54.27 | 2024-2025 | Interstim |
| Angiodynamics, INC. | $51.35 | 2025 | Nanoknife |
| C. R. Bard, INC. & Subsidiaries | $35.09 | 2025 | Bard Urinary Drainage Bag |
| Abbvie INC. | $29.96 | 2025 | |
| Agiliti Surgical, INC. | $28.78 | 2025 | Blue Light Lasers |
| Urogen Pharma, INC. | $25.10 | 2025 | |
| Calyxo, INC. | $24.49 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $23.35 | 2023 | Xtandi |
| Coloplast Corp | $21.19 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $19.77 | 2025 | |
| Antares Pharma, INC. | $19.60 | 2025 | Xyosted |
| Axonics, INC. | $17.13 | 2024 | Axonics |
| Merck Sharp & Dohme LLC | $16.73 | 2024 | Lynparza |
| Astrazeneca Pharmaceuticals LP | $15.52 | 2024 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.